CASI Pharmaceuticals
Manufacturing · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Room 1701-1703 Tower 1 Huamao Office Bui...Phone Number
+86 1065618789Website
www.casipharmaceuticals.comRevenue
$26.8 MillionStock Symbol
CASIIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About CASI Pharmaceuticals
CASI Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for cancer, autoimmune diseases, and organ transplant rejection. The company advances novel biologics, monoclonal antibodies, and oncology treatments to address unmet medical needs worldwide.Explore more
CASI Pharmaceuticals Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CASI Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CASI Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once CASI Pharmaceuticals has new funding data
Congratulate Masked Content for being promoted to Masked Content at CASI Pharmaceuticals
Earning: See what the market has to say on CASI Pharmaceuticals recently announced quarterly report
CASI Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if CASI Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if CASI Pharmaceuticals is spiking on competitors!
Product Launch: Get notified when CASI Pharmaceuticals launches new products
Recommended Actions
Reach out to Masked Content who joined CASI Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to CASI Pharmaceuticals
Compare insights from companies similar to CASI Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CASI Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CASI Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CASI Pharmaceuticals.
CASI Pharmaceuticals financials insights
Gather financial insights about CASI Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2012
Debt
$10M
2020
Debt
$350K
Unspecified
$65M
2021
Share Placement
$32.5M
2024
Share Placement
$15M
2026
Debt
$5M
Debt
$5M
CASI Pharmaceuticals Tech Stack
A closer look at the technologies used by CASI Pharmaceuticals
See more technologies
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Open Position
Seeking Replacement
Funding
Funding
Funding
Funding
Lateral Move
Executive Move
Executive Moves, Lateral Move, Board of Directors
CASI Pharmaceuticals News & Media
CASI Pharmaceuticals (CASIF) CMO holds 116333 fully vested options at $1.93
CASI Pharmaceuticals Global Chief Medical Officer Alexander Zukiwski reports 116,333 fully vested options to buy Ordinary Shares at $1.93, expiring April 20, 2027.CASI Pharmaceuticals Appoints James Huang to Board of Directors - Yahoo Finance
- Industry veteran brings over 35 years of biotech experience as a successful entrepreneur and investor- Operating experience to significantly enhance development program of CID-103 (anti-CD38 mAb) SOUTH SAN FRANCISCO, CA / ACCESS Newswire / September ...CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. ...
ACCESS Newswire is the leading global press release distribution service. Tell your story and reach millions of journalists. Contact us today to get started.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CASI Pharmaceuticals
Sign Up For FreeTo access detailed company insights
CASI Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing innovative therapies for cancer, autoimmune diseases, and organ transplant rejection. The company advances novel biologics, monoclonal antibodies, and oncology treatments to address unmet medical needs worldwide.... Read More
